Description: Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.
Home Page: www.volparahealth.com
Simpl House
Wellington,
6011
New Zealand
Phone:
64 4 499 6029
Officers
| Name | Title |
|---|---|
| Dr. Ralph P. Highnam B.Sc., M.Sc., Ph.D. | Founder, MD, Chief Scientist & Chief Science and Innotion Officer |
| Mr. Craig Hadfield | CFO & Company Sec. |
| Ms. Teri Thomas | CEO, MD & Director |
| Prof. Nico Karssemeijer | Co-Founder & Member of Scientific Board |
| Mr. Tana Isaac | Exec. VP of Product & Technology |
| Mr. Gareth Beaumont | Chief Information Officer & Chief Information Security Officer |
| Mr. Fred Struve B.Sc., J.D. | Joint Company Sec. & Gen. Counsel |
| Ms. Jill Spear | Exec. VP of Sales & Marketing |
| Ms. Kathryn Greene | Chief People Officer |
| Mr. Julian Marshall | Chief Knowledge Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.4632 |
| Price-to-Sales TTM: | 3.7101 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 189 |